The Office of Patient Advocacy (OPA) and Single Point of Access (SPA) are combined into one component of the C.W. Bill Young Cell Transplantation Program (Program). According to the Program's contract, the OPA/SPA will:
To learn about the contractor for the OPA/SPA, see National Marrow Donor Program, a Program Contractor.
Learn how this organization is fulfilling its contract.
Learn how the Program helps more patients have a successful bone marrow or umbilical cord blood transplant. The Program is authorized by the Stem Cell Therapeutic and Research Act of 2005, Public Law 109-129 and the Stem Cell Therapeutic and Research Reauthorization Act of 2010, Public Law 111-264.
A bone marrow or cord blood transplant replaces a patient's diseased cells with healthy blood-forming cells. These cells can come from the marrow of a donor or the umbilical cord blood that is collected after a baby is born.
Learn more about: